USP17L2 and hepatocellular carcinoma: Secondly, the genetic ablation of DUB3 markedly reduces the protein levels of YAP1 and its downstream targets, inhibits cell proliferation and tumor growth, and enhances chemosensitivity in HCC (Figs. 5 and S4).